{"resourceType":"Bundle","type":"searchset","entry":[{"resource":{"resourceType":"Parameters","id":"ImmDS-2013-0193","parameter":[{"name":"assessentDate","valueDate":"2020-06-29"},{"name":"patient","resource":{"resourceType":"Patient","id":"2013-0193","name":[{"text":"Dose 1 to Dose 2 interval 6 mo-4 days.  Series complete.\nEvaluation_Test_Type: Interval: At Absolute Minimum\nGeneral_Description: This test case describes when the second dose of the HepA 2 dose vaccine is administered at 6 months - 4 days, that the dose is considered valid and the series is considered complete."}],"gender":"female","birthDate":"2016-01-03"}},{"name":"immunization","resource":{"resourceType":"Immunization","id":"2013-0193-dose1","status":"completed","vaccineCode":{"coding":[{"system":"http://hl7.org/fhir/sid/cvx","code":"85","display":"Hep A, unspecified formulation"}]},"patient":{"reference":"Patient/2013-0193"},"date":"2020-01-03T00:00:00.000"}},{"name":"immunization","resource":{"resourceType":"Immunization","id":"2013-0193-dose2","status":"completed","vaccineCode":{"coding":[{"system":"http://hl7.org/fhir/sid/cvx","code":"85","display":"Hep A, unspecified formulation"}]},"patient":{"reference":"Patient/2013-0193"},"date":"2020-06-29T00:00:00.000"}}]},"request":{"method":"PUT","url":"Parameters"}}]}